Family Med Journals

Family Med

sponsor
Become a Member Today!
Register
Email:


Password:

Remember me
Forgot your Password?
Invite Code?
Article ID

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Tarantino G et al. - Risk factors for drug-induced liver injury include concomitant hepatic diseases, age and genetic polymorphisms of CYP. However, some susceptibility can be predicted before drug administration, working on the common substrate, by phenotyping and genotyping studies and by taking in consideration patients' health status. Physicians should always think of this adverse effect in the absence of other clear hepatic disease. Ethical and legal problems towards operators in the health care system are always matters to consider.

Related Articles

The Pathology of Drug-Induced Liver Injury
Seminars in Liver Disease, 10/16/09    Relevance Score: 68%

The Natural History of Drug-Induced Liver Injury
Seminars in Liver Disease, 10/15/09    Relevance Score: 68%

Statin therapy initiated in a man with hepatitis C and elevated cholesterol
The Clinical Advisor, 10/07/09    Relevance Score: 68%

Treatment for Graves' Disease Poses Risk of Liver Failure
American Journal of Nursing, 10/01/09    Relevance Score: 68%

Biochemical mechanisms in drug-induced liver injury: Certainties and doubts
World Journal of Gastroenterology, 10/26/09    Relevance Score: 67%

Today in Gastroenterology...keeping you current

Test-and-treat strategy for Helicobacter pylori (HP) infection in older patients
Archives of Gerontology and Geriatrics, 12/20/09

A prospective phase II study of cetuximab in combination with XELOX (capecitabine and oxaliplatin) in patients with metastatic and/or recurrent advanced gastric cancer
Investigational New Drugs, 12/18/09

Ipmn penetration of the stomach
Digestive Endoscopy, 12/18/09


Sponsor

Article Search

Keyword:

Search:

Published within

Sort By:
Date
Relevance


Sponsor

Sponsor

Send this Summary to a Colleague

Enter email address